Fagomine

Details

Top
Internal ID 9302125b-62a1-4120-9140-2a98d4244a8d
Taxonomy Organoheterocyclic compounds > Piperidines
IUPAC Name (2R,3R,4R)-2-(hydroxymethyl)piperidine-3,4-diol
SMILES (Canonical) C1CNC(C(C1O)O)CO
SMILES (Isomeric) C1CN[C@@H]([C@H]([C@@H]1O)O)CO
InChI InChI=1S/C6H13NO3/c8-3-4-6(10)5(9)1-2-7-4/h4-10H,1-3H2/t4-,5-,6-/m1/s1
InChI Key YZNNBIPIQWYLDM-HSUXUTPPSA-N
Popularity 59 references in papers

Physical and Chemical Properties

Top
Molecular Formula C6H13NO3
Molecular Weight 147.17 g/mol
Exact Mass 147.08954328 g/mol
Topological Polar Surface Area (TPSA) 72.70 Ų
XlogP -1.40
Atomic LogP (AlogP) -1.94
H-Bond Acceptor 4
H-Bond Donor 4
Rotatable Bonds 1

Synonyms

Top
53185-12-9
D-Fagomine
(2r,3r,4r)-2-(hydroxymethyl)piperidine-3,4-diol
1,2,5-Trideoxy-1,5-imino-D-arabino-hexitol
3,4-Piperidinediol, 2-(hydroxymethyl)-, (2R,3R,4R)-
UNII-1M10C1P4SM
1M10C1P4SM
CHEBI:4969
CHEMBL108084
FAG
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Fagomine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6892 68.92%
Caco-2 - 0.9270 92.70%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability + 0.6857 68.57%
Subcellular localzation Mitochondria 0.7186 71.86%
OATP2B1 inhibitior - 0.8479 84.79%
OATP1B1 inhibitior + 0.9644 96.44%
OATP1B3 inhibitior + 0.9511 95.11%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.9489 94.89%
P-glycoprotein inhibitior - 0.9803 98.03%
P-glycoprotein substrate - 0.9120 91.20%
CYP3A4 substrate - 0.6610 66.10%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate + 0.4714 47.14%
CYP3A4 inhibition - 0.9920 99.20%
CYP2C9 inhibition - 0.9440 94.40%
CYP2C19 inhibition - 0.9536 95.36%
CYP2D6 inhibition - 0.9221 92.21%
CYP1A2 inhibition - 0.9093 90.93%
CYP2C8 inhibition - 0.9820 98.20%
CYP inhibitory promiscuity - 0.9909 99.09%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9500 95.00%
Carcinogenicity (trinary) Non-required 0.7200 72.00%
Eye corrosion - 0.8993 89.93%
Eye irritation - 0.6357 63.57%
Skin irritation - 0.6491 64.91%
Skin corrosion - 0.8684 86.84%
Ames mutagenesis - 0.6600 66.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5923 59.23%
Micronuclear - 0.5200 52.00%
Hepatotoxicity + 0.5139 51.39%
skin sensitisation - 0.8654 86.54%
Respiratory toxicity - 0.6556 65.56%
Reproductive toxicity + 0.6556 65.56%
Mitochondrial toxicity + 0.8000 80.00%
Nephrotoxicity - 0.5622 56.22%
Acute Oral Toxicity (c) III 0.6909 69.09%
Estrogen receptor binding - 0.8999 89.99%
Androgen receptor binding - 0.7817 78.17%
Thyroid receptor binding - 0.7939 79.39%
Glucocorticoid receptor binding - 0.8251 82.51%
Aromatase binding - 0.8320 83.20%
PPAR gamma - 0.8318 83.18%
Honey bee toxicity - 0.9400 94.00%
Biodegradation + 0.6750 67.50%
Crustacea aquatic toxicity - 0.7100 71.00%
Fish aquatic toxicity - 0.9928 99.28%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3137262 O60341 LSD1/CoREST complex 96.28% 97.09%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.64% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 92.00% 97.25%
CHEMBL226 P30542 Adenosine A1 receptor 91.83% 95.93%
CHEMBL1907589 P17787 Neuronal acetylcholine receptor; alpha4/beta2 90.84% 94.55%
CHEMBL4394 Q9NYA1 Sphingosine kinase 1 85.54% 96.03%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 83.78% 91.11%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.51% 95.89%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 81.86% 96.21%
CHEMBL1994 P08235 Mineralocorticoid receptor 80.74% 100.00%

Cross-Links

Top
PubChem 72259
NPASS NPC76726
ChEMBL CHEMBL108084
LOTUS LTS0252575
wikiData Q21086897